Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.
about
Screening for prostate cancerScreening for prostate cancerMortality results from a randomized prostate-cancer screening trialProstate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic AnalysisProstate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based AnalysisProstate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam.Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.Mortality results from the Göteborg randomised population-based prostate-cancer screening trialWhat happens after an elevated PSA test: the experience of 13,591 veterans.A dual-reporter, diagnostic vector for prostate cancer detection and tumor imaging.Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: a qualitative study.What do the screening trials really tell us and where do we go from here?Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA.Historical prostate cancer screening and treatment outcomes from a single institutionThe prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines.Biopsy follow-up of prostate-specific antigen tests.The impact of PLCO control arm contamination on perceived PSA screening efficacy.Analysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate HyperplasiaFive-year downstream outcomes following prostate-specific antigen screening in older menWhat we have learned from randomized trials of prostate cancer screening.Early prostate-specific antigen changes and the diagnosis and prognosis of prostate cancerImaging modalities for prostate cancer.PSA levels of 4.0 - 10 ng/mL and negative digital rectal examination. Antibiotic therapy versus immediate prostate biopsy.Should prostate-specific antigen screening be offered to asymptomatic men?The implementation of screening for prostate cancer.The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: the prostate cancer screening results in context.Molecular genetics of prostate cancer: emerging appreciation of genetic complexity.Landmarks in prostate cancer screening.A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray.Molecular biomarkers in prostate cancer.Prostate-specific antigen-based prostate cancer screening: Past and future.Prostate Cancer Prevention: Concepts and Clinical Trials.Prostate cell lines as models for biomarker discovery: performance of current markers and the search for new biomarkers.Prostate cancer prediction using the random forest algorithm that takes into account transrectal ultrasound findings, age, and serum levels of prostate-specific antigen.Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.High PCA3 scores in urine correlate with poor-prognosis factors in prostate cancer patients.Data to support PSA screening for younger men lacking.Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial.Implications of the new AUA guidelines on prostate cancer detection in the U.S.
P2860
Q24201690-E950EFA4-AC68-42C9-84E3-1E9694E5F28EQ24245476-68146A7E-6BC5-4B78-B64F-599D64D7926CQ24601536-6211A455-B952-4428-9334-196F98023BF0Q26781089-04CE7B6D-ECF9-4E42-889F-EB899215851FQ26781093-563EB414-8647-4373-9A5F-6D7B1ABCFFB3Q33698755-12241806-B874-4652-9805-25AE6B96AAE5Q33863050-FD7CD64C-45BD-4B7A-A13D-FC19DE9DE796Q33873969-165CC3A8-862E-4785-B015-00E693A4187CQ34164258-AA372890-7DE4-4BEA-9480-22E088D0C508Q35151488-90BAE88F-8634-44D5-B5AD-A16280100E22Q35204021-F85406D8-3F30-43B9-8F4A-7DDA800CA0C5Q35234770-A2AE1ABB-C824-409A-B273-20537B7EFB10Q35562732-3DF88B87-2DD4-48D4-87F5-576BFDCBD457Q35632848-50E66260-5171-4625-8689-6E32EAD9E8C6Q36170995-A3A6011D-6A79-4D82-AE8E-9718F4447E72Q36179431-F64E6401-15B7-428A-87E4-2617E7FDB4D4Q36567436-D0DFF290-8D68-4929-B158-49313254CF18Q36567476-04A92FEC-85D7-4910-BB4A-210F4C9C5AE2Q36737765-E79A2683-3784-46B5-AACB-1263CAA6961BQ37017183-CE0C7E2F-E5F0-49C4-A083-FD3840F17979Q37084639-2DFA4C3A-3519-491C-A13A-BF4D54751FCEQ37422990-D3FEA64B-E8DE-4A42-8874-8942E2595620Q37546036-B01C7FCC-F2AA-4ADA-8F3E-C28B336A017FQ37622493-00CCE62C-E877-4ACC-9A5F-0D31237064E6Q37774352-09F54F0D-CF00-4EA0-92EE-80B8792CEA05Q37777325-A8E3B3BE-673B-4AE9-AE62-8C72B030EB71Q37878463-55AD0AE3-D746-44BD-B923-54B1F631ACE9Q37972706-86419E1B-165E-4FC7-ABEC-5035F851C476Q38050464-29CD4AC2-056F-4F53-9A0E-0760BA0EF5CAQ38066715-B5846C41-3BB5-4404-8B2D-4F3BD9D74B35Q38088854-E8871D2D-5423-47F3-8A6F-7C744A4ADB0DQ38408501-D592C272-F65B-4F21-A941-CD145EAC4E8EQ38766396-A324DED9-86CB-40BA-8F29-646668F10E63Q39033586-567E419F-9D34-4D55-A9BB-E5AC9B8777FEQ39431092-8FF0BC6A-7BC1-45A0-A879-0D11A1C70AD5Q40259797-956AF0C7-761C-43BC-9907-5DE1F614EB71Q40335045-96B545E0-8DA3-4503-83BA-61E3B0519752Q43235126-72D25907-DB4E-4CD3-98B6-41D3559EDAD2Q46482531-08EC402E-D22B-4CC9-A18C-1E59ED70DAC0Q46619813-C3518559-B70B-4F16-B4EB-291987E08005
P2860
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Prostate cancer screening in t ...... reening in a randomized trial.
@en
Prostate cancer screening in t ...... reening in a randomized trial.
@nl
type
label
Prostate cancer screening in t ...... reening in a randomized trial.
@en
Prostate cancer screening in t ...... reening in a randomized trial.
@nl
prefLabel
Prostate cancer screening in t ...... reening in a randomized trial.
@en
Prostate cancer screening in t ...... reening in a randomized trial.
@nl
P2093
P1433
P1476
Prostate cancer screening in t ...... reening in a randomized trial.
@en
P2093
Anthony B Miller
Barnett S Kramer
Christine D Berg
David Chia
David L Levin
Donald A Urban
Douglas J Reding
E David Crawford
Edward P Gelmann
Gerald L Andriole
P304
P356
10.1111/J.1464-410X.2008.08214.X
P577
2008-12-01T00:00:00Z